ES543828A0 - Un metodo de producir un preparado farmaceutico en forma de dosificacion unitaria de un medicamento esteroide solido - Google Patents

Un metodo de producir un preparado farmaceutico en forma de dosificacion unitaria de un medicamento esteroide solido

Info

Publication number
ES543828A0
ES543828A0 ES543828A ES543828A ES543828A0 ES 543828 A0 ES543828 A0 ES 543828A0 ES 543828 A ES543828 A ES 543828A ES 543828 A ES543828 A ES 543828A ES 543828 A0 ES543828 A0 ES 543828A0
Authority
ES
Spain
Prior art keywords
producing
pharmaceutical preparation
solid
unit dosing
steroid medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES543828A
Other languages
English (en)
Other versions
ES8608865A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sterwin AG
Original Assignee
Sterwin AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterwin AG filed Critical Sterwin AG
Publication of ES8608865A1 publication Critical patent/ES8608865A1/es
Publication of ES543828A0 publication Critical patent/ES543828A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Control Of El Displays (AREA)
  • Compounds Of Unknown Constitution (AREA)
ES543828A 1984-06-04 1985-06-03 Un metodo de producir un preparado farmaceutico en forma de dosificacion unitaria de un medicamento esteroide solido Expired ES8608865A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848414221A GB8414221D0 (en) 1984-06-04 1984-06-04 Unit dosage form

Publications (2)

Publication Number Publication Date
ES8608865A1 ES8608865A1 (es) 1986-07-16
ES543828A0 true ES543828A0 (es) 1986-07-16

Family

ID=10561913

Family Applications (1)

Application Number Title Priority Date Filing Date
ES543828A Expired ES8608865A1 (es) 1984-06-04 1985-06-03 Un metodo de producir un preparado farmaceutico en forma de dosificacion unitaria de un medicamento esteroide solido

Country Status (20)

Country Link
US (1) US4717569A (es)
EP (1) EP0164967B1 (es)
JP (1) JPS611613A (es)
KR (1) KR860000067A (es)
AT (1) ATE56357T1 (es)
AU (1) AU578474B2 (es)
CA (1) CA1242646A (es)
DE (1) DE3579631D1 (es)
DK (1) DK164355C (es)
ES (1) ES8608865A1 (es)
FI (1) FI84783C (es)
GB (1) GB8414221D0 (es)
GR (1) GR851355B (es)
IL (1) IL75372A (es)
MX (1) MX161943A (es)
NO (1) NO166918C (es)
NZ (1) NZ212255A (es)
PH (1) PH22173A (es)
PT (1) PT80584B (es)
ZA (1) ZA854115B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3440288A1 (de) * 1984-11-05 1986-05-07 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung
GB2176999B (en) * 1985-06-22 1989-07-12 Stanley Stewart Davis Sustained release medicament
US4833133A (en) * 1986-05-22 1989-05-23 Sterling Drug Inc. Method of regulating fertility in cattle using epostane
US4870068A (en) * 1986-05-22 1989-09-26 Sterling Drug Inc. Method of regulating fertility in swine using epostane
JP2680614B2 (ja) * 1988-08-01 1997-11-19 日清製粉株式会社 ダナゾール組成物
JP2773895B2 (ja) * 1989-04-25 1998-07-09 東京田辺製薬株式会社 ダナゾール組成物
JP2542122B2 (ja) * 1990-04-18 1996-10-09 旭化成工業株式会社 球状核、球形顆粒およびその製造方法
DE69111287T2 (de) * 1990-04-18 1995-12-21 Asahi Chemical Ind Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung.
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5573783A (en) * 1995-02-13 1996-11-12 Nano Systems L.L.C. Redispersible nanoparticulate film matrices with protective overcoats
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
FR2795961B1 (fr) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
JP3386052B2 (ja) * 2001-02-13 2003-03-10 トヨタ自動車株式会社 ポンプ装置
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
FR2842736B1 (fr) * 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
GB2400554B (en) * 2003-04-16 2007-04-18 George Margetts Treatment of angiotensin II-induced cardiovascular disease
WO2005030181A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Controlled release formulations of opioid and nonopioid analgesics
US20070259033A1 (en) * 2003-09-26 2007-11-08 Evangeline Cruz Controlled release formulations exhibiting an ascending rate of release
AU2004314693B2 (en) * 2003-09-26 2011-04-07 Alza Corporation Drug coating providing high drug loading and methods for providing the same
KR20060115860A (ko) * 2003-09-26 2006-11-10 알자 코포레이션 활성 제제의 서방성 전달을 위한 ｏｒｏｓ 푸시-스틱
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
FR2885526B1 (fr) * 2005-05-13 2007-07-27 Flamel Technologies Sa Medicament oral a base d'inhibiteur de pompe a protons
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US20080096819A1 (en) * 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
US7632492B2 (en) * 2006-05-02 2009-12-15 Allozyne, Inc. Modified human interferon-β polypeptides
CA2707840A1 (en) * 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
CA2718416C (en) * 2008-03-13 2018-01-02 Mallinckrodt Inc. Multi-function, foot-activated controller for imaging system
PL2328539T3 (pl) 2008-09-25 2018-09-28 Isp Investments Llc Gładka tabletkowa kompozycja powlekająca z wysoką zawartością ciał stałych
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
CN103313703A (zh) * 2010-12-27 2013-09-18 富田制药株式会社 制剂用崩解型核粒子
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB742007A (en) * 1953-04-01 1955-12-14 Smith Kline & French Internat Improvements in or relating to method of forming coated pharmaceutical pellets
GB765086A (en) * 1954-11-19 1957-01-02 Smith Kline & French Internat Anticholinergic preparation
GB785262A (en) * 1955-09-23 1957-10-23 Smith Kline & French Internat Improvements in or relating to hypotensive and sedative preparations
GB844772A (en) * 1956-04-19 1960-08-17 Pfizer & Co C Granular pharmaceutical compositions and process for preparing same
US3328256A (en) * 1963-05-27 1967-06-27 William E Gaunt Spherical beads and their production
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
AT336190B (de) * 1974-07-23 1977-04-25 Hurka Wilhelm Verfahren zur herstellung von mikropellets zur behandlung von erkrankungen des mund- und rachenraumes
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
DE3126703A1 (de) * 1981-07-07 1983-01-27 Dr. Karl Thomae Gmbh, 7950 Biberach Bromhexin-retardform und verfahren zu ihrer herstellung
FR2510582B1 (fr) * 1981-07-30 1986-05-30 Sipsy Steroides esterifies en la position 17 et thio-esterifies en la position 21, leur procede de preparation et leur application comme medicament
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof

Also Published As

Publication number Publication date
IL75372A0 (en) 1985-09-29
EP0164967A2 (en) 1985-12-18
IL75372A (en) 1989-08-15
DK164355B (da) 1992-06-15
AU578474B2 (en) 1988-10-27
KR860000067A (ko) 1986-01-25
NZ212255A (en) 1988-06-30
DK247485A (da) 1985-12-05
NO852226L (no) 1985-12-05
PT80584A (en) 1985-07-01
NO166918B (no) 1991-06-10
GB8414221D0 (en) 1984-07-11
DK164355C (da) 1992-11-02
EP0164967B1 (en) 1990-09-12
ES8608865A1 (es) 1986-07-16
GR851355B (es) 1985-11-25
FI852236A0 (fi) 1985-06-04
NO166918C (no) 1991-09-18
CA1242646A (en) 1988-10-04
ZA854115B (en) 1986-01-29
PT80584B (pt) 1987-09-18
PH22173A (en) 1988-06-28
JPS611613A (ja) 1986-01-07
FI852236L (fi) 1985-12-05
FI84783B (fi) 1991-10-15
DE3579631D1 (de) 1990-10-18
AU4323785A (en) 1985-12-12
DK247485D0 (da) 1985-06-03
FI84783C (fi) 1992-01-27
MX161943A (es) 1991-03-08
ATE56357T1 (de) 1990-09-15
EP0164967A3 (en) 1986-12-30
US4717569A (en) 1988-01-05

Similar Documents

Publication Publication Date Title
ES543828A0 (es) Un metodo de producir un preparado farmaceutico en forma de dosificacion unitaria de un medicamento esteroide solido
ES248348Y (es) Inhalador para substancias medicinales pulverulentas con unafuncion combinada de alimentador para administracion de do- sis
DE3268533D1 (en) Inhalation drugs, methods for their production and pharmaceutical formulations containing them
MY8500052A (en) 2-penem compounds, a method for their preparation and pharmaceutical compositions comprising them
DE3366393D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
PT80583A (en) Pharmaceutical composition in sustained release unit dose form and process for its preparation
DE3483899D1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische praeparate.
ES508185A0 (es) Un procedimiento para preparar una composicion farmaceutica en forma de dosis mitarica.
DE3160805D1 (en) Antiallergic imidodisulfamides, pharmaceutical compositions containing them and process for their preparation
PT76853A (fr) Procede de preparation de compositions pharmaceutiques a base de xylosides et lyxosides de base puriques et pyrimidiques
ZA836512B (en) Sulfamoylbenzophenone derivatives,a process for their preparation,their use and pharmaceutical products based on these compounds
LU84492A1 (de) Cumarin-derivate,verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische praeparate
ZA838463B (en) Heterocyclylthio compounds,processes for their manufacture,pharmaceutical preparations that contain these compounds,and the use of the latter
AR242380A1 (es) Procedimiento de preparacion de derivados de piperidinilmetil-fenoxi-aminopropanol-2-
DE3160050D1 (en) 3-desoxy-delta-15 steroids, process for their preparation and pharmaceutical compositions containing them
ATE20069T1 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ZA817395B (en) 1-carboxyalkanoylindoline-2-carboxylic acids,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application
DE3062648D1 (en) 2-penem compounds, a method for their preparation and pharmaceutical compositions comprising them
ZA834471B (en) Benzene derivatives,processes for their preparation and pharmaceutical compositions comprising them
ATE23168T1 (de) 11-beta-aryl-estradiene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
BE874773A (fr) Compose pharmaceutique nouveau et procede de preparation de celui-ci
ATE24511T1 (de) Tricyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE32073T1 (de) Karbonsaeureamidguanidine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE31534T1 (de) Cyanguanidine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE19403T1 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203